Drug Repurposing in the Development of Anticancer Agents
Author:
Affiliation:
1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Biruni University, Istanbul, Turkey
2. Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, M5S 3M2, Canada
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference127 articles.
1. Nosengo N.; New tricks for old drugs. Nature 2016,534,314-316
2. Ashburn T.T.; Thor K.B.; Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004,3(8),673-683
3. Chen H.; Wu J.; Gao Y.; Chen H.; Zhou J.; Scaffold repurposing of old drugs towards new cancer drug discovery. Curr Top Med Chem 2016,16(19),2107-2114
4. Andronis C.; Sharma A.; Virvilis V.; Deftereos S.; Persidis A.; Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform 2011,12(4),357-368
5. March-Vila E.; Pinzi L.; Sturm N.; Tinivella A.; Engkvist O.; Chen H.; Rastelli G.; On the Integration of in silico drug design methods for drug repurposing. Front Pharmacol 2017,8,298-304
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Calcium channel blockers are associated with improved survival in pancreatic cancer patients undergoing neoadjuvant chemotherapy and resection;HPB;2023-12
2. The tale of antibiotics beyond antimicrobials: Expanding horizons;Cytokine;2023-09
3. Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process;Current Cancer Drug Targets;2023-05
4. New drug approvals for 2021: Synthesis and clinical applications;European Journal of Medicinal Chemistry;2023-01
5. Reverse Translational Approach in Repurposing of Drugs for Anticancer Therapy;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3